Patent details

Basic Information

Publication number:

EP2340828

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP101760940

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMBINATIONS OF AN ANGIOTENSIN RECEPTOR ANTAGONIST AND A NEP INHIBITOR

French Title of Invention:

COMBIAISONS PHARMACEUTIQUES D'UN ANTAGONISTE DU RECEPTEUR DE L'ANGIOTENSINE ET UN INHIBITEUR DE NEP

German Title of Invention:

PHARMAZEUTISCHE KOMBINATIONEN AUS EINEM ANGIOTENSINREZEPTOR-ANTAGONISTEN UND EINEM NEP-HEMMER

SPC Number:

LUC00195

Dates

Filing date:

08/11/2006

Grant date:

15/07/2020

EP Publication Date:

06/07/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/07/2020

EP B1 Publication Date:

15/07/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

08/11/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/12/2020

 

 

Name:

Novartis Pharma AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:

08/07/2020

To:

11/12/2020

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Girgis, Michael J.

Address:

United States (US)

2

Name:

Karpinski, Piotr

Address:

United States (US)

3

Name:

Feng, Lili

Address:

United States (US)

4

Name:

Prashad, Mahavir

Address:

United States (US)

5

Name:

Hu, Bin

Address:

United States (US)

6

Name:

Liu, Yugang

Address:

United States (US)

7

Name:

Godtfredsen, Sven Erik

Address:

United States (US)

8

Name:

Blacklock, Thomas

Address:

United States (US)

9

Name:

Sutton, Paul Allen

Address:

United States (US)

Priority

1

Priority Number:

735093 P

Priority Date:

09/11/2005

Priority Country:

United States (US)

2

Priority Number:

735541 P

Priority Date:

10/11/2005

Priority Country:

United States (US)

3

Priority Number:

789332 P

Priority Date:

04/04/2006

Priority Country:

United States (US)

4

Priority Number:

822086 P

Priority Date:

11/08/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/216; A61K 31/41; A61P 3/10; A61P 9/00; A61P 9/10; A61P 9/12; A61P 25/06; A61P 25/28; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:

202029

Publication date:

15/07/2020

Description:

Grant (B1)

2

Issue number:

202120

Publication date:

19/05/2021

Description:

Opposition procedure started

3

Issue number:

202119

Publication date:

12/05/2021

Description:

Opposition procedure started

4

Issue number:

202102

Publication date:

13/01/2021

Description:

Transfer of Rights

Annual Fees

Annual Fee Due Date:

01/12/2025

Annual Fee Number:

20

Annual Fee Amount:

300 Euro

Expected Payer:

Last Annual Fee Payment Date:

25/10/2024

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

CPA GLOBAL THE IP PLATFORM